A Clinical Trial to Study the Effects of Ayurvedic Tambula ingredients and Processed Ayurvedic Tambula Grannules in Pre-diabetes patients.
Phase 1
- Conditions
- Health Condition 1: R739- Hyperglycemia, unspecified
- Registration Number
- CTRI/2021/02/031539
- Lead Sponsor
- Dr Santosh Dadu Kamble
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Fasting glucose between 100 and 125 mg per dl or postprandial glucose of 140 to 199 mg per dl
With signs and symptoms of Prameha and Pre Diabetes
Family history of diab�¨tes.
Daily Minimum physical activity
Age 30 years to 60 years
Sex Both male and female
Overweight individuals.
Exclusion Criteria
Pre-diagnosed DM Type II patients
Insulin dependent DM
Evidence of any acute metabolic, vascular, infective complications
Abnormal LFT, RFT
Pregnancy and lactating mother
Unable to provide written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chewing of Ayurvedic Tambula Sevana is an effective daily regimen for Diabetes Prevention in Pre-Diabetes(impaired glucose tolerence).Timepoint: 60 Days Study with 4 Follow ups (15,30,45 and 60 days)
- Secondary Outcome Measures
Name Time Method Chewing of Ayurvedic Tambula Sevana Improves Digestion.Timepoint: 15 days